ARROWHEAD PHARMACEUTICALS IN

Arrowhead Insider Sale Signals Confidence Amid Gene‑Silencing Surge

Arrowhead Pharmaceuticals insider sale: Olukotun Adeoye sells 2,000 shares amid 2‑week price surge. Is it a confidence signal or a warning? Find out.

ARROWHEAD PHARMACEUTICALS IN
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

20/08/2026, 23:41

5 minutes to read

Arrowhead Insider Buy Signals Confidence as Gene‑Silencing Stock Surges 429% YTD

Arrowhead Pharmaceuticals insider activity shows board member Matthew Cohen buying 11,882 shares at zero cost, reflecting confidence in the company’s RNAi platform and potential Phase III breakthrough.

ARROWHEAD PHARMACEUTICALS IN
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

18/06/2026, 03:59

4 minutes to read